{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:22:34Z","timestamp":1790637754486,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    -adrenergic receptors (\u03b2\n                    <jats:sub>1<\/jats:sub>\n                    ARs) mediate catecholamine actions in cardiomyocytes by coupling to both Gs\/cAMP-dependent and Gs-independent\/growth-regulatory pathways. Structural studies of the \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    AR define ligand-binding sites in the transmembrane helices and effector docking sites at the intracellular surface of the \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    AR, but the extracellular N-terminus, which is a target for post-translational modifications, typically is ignored. This study identifies \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    AR N-terminal O-glycosylation at Ser\n                    <jats:sup>37<\/jats:sup>\n                    \/Ser\n                    <jats:sup>41<\/jats:sup>\n                    as a mechanism that prevents \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    AR N-terminal cleavage. We used an adenoviral overexpression strategy to show that both full-length\/glycosylated \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    ARs and N-terminally truncated glycosylation-defective \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    ARs couple to cAMP and ERK-MAPK signaling pathways in cardiomyocytes. However, a glycosylation defect that results in N-terminal truncation stabilizes \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    ARs in a conformation that is biased toward the cAMP pathway. The identification of O-glycosylation and N-terminal cleavage as novel structural determinants of \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    AR responsiveness in cardiomyocytes could be exploited for therapeutic advantage.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-06607-z","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T04:26:40Z","timestamp":1502080000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["\u03b21-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes"],"prefix":"10.1038","volume":"7","author":[{"given":"Misun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopireddy R.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wallukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-9143","authenticated-orcid":false,"given":"Yang K.","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"6607_CR1","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1172\/JCI31901","volume":"117","author":"T Noma","year":"2007","unstructured":"Noma, T. et al. \u03b2-Arrestin-mediated \u03b21-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117, 2445\u20132458 (2007).","journal-title":"J Clin Invest"},{"key":"6607_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1006\/jmcc.2001.1358","volume":"33","author":"JD Port","year":"2001","unstructured":"Port, J. D. & Bristow, M. R. Altered \u03b2-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 33, 887\u2013905 (2001).","journal-title":"J Mol Cell Cardiol"},{"key":"6607_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","volume":"93","author":"MJ Lohse","year":"2003","unstructured":"Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of \u03b2-adrenergic signaling in heart failure? Circ Res 93, 896\u2013906 (2003).","journal-title":"Circ Res"},{"key":"6607_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08650","volume":"463","author":"MP Bokoch","year":"2010","unstructured":"Bokoch, M. P. et al. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463, 108\u2013112 (2010).","journal-title":"Nature"},{"key":"6607_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1126\/science.1150609","volume":"318","author":"DM Rosenbaum","year":"2007","unstructured":"Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into \u03b22-adrenergic receptor function. Science 318, 1266\u20131273 (2007).","journal-title":"Science"},{"key":"6607_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature06325","volume":"450","author":"SG Rasmussen","year":"2007","unstructured":"Rasmussen, S. G. et al. Crystal structure of the human \u03b22-adrenergic G-protein-coupled receptor. Nature 450, 383\u2013387 (2007).","journal-title":"Nature"},{"key":"6607_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1752-8062.2008.00059.x","volume":"1","author":"GW Dorn 2nd","year":"2008","unstructured":"Dorn, G. W. 2nd & Liggett, S. B. Pharmacogenomics of \u03b2-adrenergic receptors and their accessory signaling proteins in heart failure. Clin Transl Sci 1, 255\u2013262 (2008).","journal-title":"Clin Transl Sci"},{"key":"6607_CR8","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.jmb.2016.03.025","volume":"428","author":"P Stanley","year":"2016","unstructured":"Stanley, P. What have we learned from glycosyltransferase knockouts in mice? J Mol Biol 428, 3166\u20133182 (2016).","journal-title":"J Mol Biol"},{"key":"6607_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10719-008-9162-4","volume":"26","author":"E Tian","year":"2009","unstructured":"Tian, E. & Ten Hagen, K. G. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J 26, 325\u2013334 (2009).","journal-title":"Glycoconj J"},{"key":"6607_CR10","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1074\/jbc.R112.418558","volume":"288","author":"DT Tran","year":"2013","unstructured":"Tran, D. T. & Ten Hagen, K. G. Mucin-type O-glycosylation during development. J Biol Chem 288, 6921\u20136929 (2013).","journal-title":"J Biol Chem"},{"key":"6607_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00216-016-9880-6","volume":"409","author":"MJ Kailemia","year":"2017","unstructured":"Kailemia, M. J., Park, D. & Lebrilla, C. B. Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem 409, 395\u2013410 (2017).","journal-title":"Anal Bioanal Chem"},{"key":"6607_CR12","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1016\/S0021-9258(18)87012-0","volume":"265","author":"E Rands","year":"1990","unstructured":"Rands, E. et al. Mutational analysis of \u03b2-adrenergic receptor glycosylation. J Biol Chem 265, 10759\u201310764 (1990).","journal-title":"J Biol Chem"},{"key":"6607_CR13","doi-asserted-by":"publisher","first-page":"28850","DOI":"10.1074\/jbc.M110.149989","volume":"285","author":"AE Hakalahti","year":"2010","unstructured":"Hakalahti, A. E. et al. Human \u03b21-adrenergic receptor Is subject to constitutive and regulated N-terminal cleavage. J Biol Chem 285, 28850\u201328861 (2010).","journal-title":"J Biol Chem"},{"key":"6607_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0006-291X(02)02259-3","volume":"297","author":"J He","year":"2002","unstructured":"He, J., Xu, J., Castleberry, A. M., Lau, A. G. & Hall, R. A. Glycosylation of \u03b21-adrenergic receptors regulates receptor surface expression and dimerization. Biochem Biophys Res Commun. 297, 565\u2013572 (2002).","journal-title":"Biochem Biophys Res Commun."},{"key":"6607_CR15","doi-asserted-by":"publisher","first-page":"10770","DOI":"10.1074\/jbc.M207968200","volume":"278","author":"J Xu","year":"2003","unstructured":"Xu, J. et al. Heterodimerization of \u03b12A and \u03b21-adrenergic receptors. J Biol Chem 278, 10770\u201310777 (2003).","journal-title":"J Biol Chem"},{"key":"6607_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.hfc.2009.08.011","volume":"6","author":"SB Liggett","year":"2010","unstructured":"Liggett, S. B. Pharmacogenomics of \u03b21-adrenergic receptor polymorphisms in heart failure. Heart Fail.Clin. 6, 27\u201333 (2010).","journal-title":"Heart Fail.Clin."},{"key":"6607_CR17","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1016\/j.bmc.2005.04.085","volume":"13","author":"HC Hang","year":"2005","unstructured":"Hang, H. C. & Bertozzi, C. R. The chemistry and biology of mucin-type O-linked glycosylation. Bioorg Med Chem 13, 5021\u20135034 (2005).","journal-title":"Bioorg Med Chem"},{"key":"6607_CR18","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1021\/bi00334a041","volume":"24","author":"R Jurss","year":"1985","unstructured":"Jurss, R., Hekman, M. & Helmreich, E. J. Proteolysis-associated deglycosylation of \u03b21-adrenergic receptor in turkey erythrocytes and membranes. Biochemistry 24, 3349\u20133354 (1985).","journal-title":"Biochemistry"},{"key":"6607_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0092-8674(86)90841-X","volume":"44","author":"DM Kingsley","year":"1986","unstructured":"Kingsley, D. M., Kozarsky, K. F., Hobbie, L. & Krieger, M. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal\/UDP-GalNAc 4-epimerase deficient mutant. Cell 44, 749\u2013759 (1986).","journal-title":"Cell"},{"key":"6607_CR20","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1128\/MCB.8.8.3357","volume":"8","author":"KF Kozarsky","year":"1988","unstructured":"Kozarsky, K. F., Call, S. M., Dower, S. K. & Krieger, M. Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors. Mol Cell Biol 8, 3357\u20133363 (1988).","journal-title":"Mol Cell Biol"},{"key":"6607_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00210-009-0392-1","volume":"379","author":"N Hamdani","year":"2009","unstructured":"Hamdani, N. & van der Velden, J. Lack of specificity of antibodies directed against human \u03b2-adrenergic receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 379, 403\u2013407 (2009).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"6607_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrd2854","volume":"8","author":"P Kirkpatrick","year":"2009","unstructured":"Kirkpatrick, P. Specificity concerns with antibodies for receptor mapping. Nat Rev Drug Discov 8, 278 (2009).","journal-title":"Nat Rev Drug Discov"},{"key":"6607_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/45816","volume":"401","author":"TT Cao","year":"1999","unstructured":"Cao, T. T., Deacon, H. W., Reczek, D., Bretscher, A. & von Zastrow, M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the \u03b22-adrenergic receptor. Nature 401, 286\u2013290 (1999).","journal-title":"Nature"},{"key":"6607_CR24","doi-asserted-by":"publisher","first-page":"41447","DOI":"10.1074\/jbc.M006951200","volume":"275","author":"VO Rybin","year":"2000","unstructured":"Rybin, V. O., Xu, X., Lisanti, M. P. & Steinberg, S. F. Differential targeting of \u03b2-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. J Biol Chem 275, 41447\u201341457 (2000).","journal-title":"J Biol Chem"},{"key":"6607_CR25","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1073\/pnas.93.14.7375","volume":"93","author":"DK Rohrer","year":"1996","unstructured":"Rohrer, D. K. et al. Targeted disruption of the mouse \u03b21-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA 93, 7375\u20137380 (1996).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6607_CR26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0026-895X(25)13350-6","volume":"33","author":"CP Moxham","year":"1988","unstructured":"Moxham, C. P., Ross, E. M., George, S. T. & Malbon, C. C. \u03b2-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution. Mol Pharm 33, 486\u2013492 (1988).","journal-title":"Mol Pharm"},{"key":"6607_CR27","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1073\/pnas.0905414106","volume":"106","author":"ML Montpetit","year":"2009","unstructured":"Montpetit, M. L. et al. Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci USA 106, 16517\u201316522 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6607_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.str.2012.03.014","volume":"20","author":"T Warne","year":"2012","unstructured":"Warne, T., Edwards, P. C., Leslie, A. G. & Tate, C. G. Crystal structures of a stabilized \u03b21-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure 20, 841\u2013849 (2012).","journal-title":"Structure"},{"key":"6607_CR29","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1073\/pnas.1117862109","volume":"109","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts. Proc Natl Acad Sci USA 109, 6578\u20136583 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6607_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvs350","volume":"97","author":"B Bornholz","year":"2013","unstructured":"Bornholz, B. et al. Impact of human autoantibodies on \u03b21-adrenergic receptor conformation, activity, and internalization. Cardiovasc Res 97, 472\u2013480 (2013).","journal-title":"Cardiovasc Res"},{"key":"6607_CR31","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/emboj.2013.79","volume":"32","author":"C Steentoft","year":"2013","unstructured":"Steentoft, C. et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32, 1478\u20131488 (2013).","journal-title":"EMBO J"},{"key":"6607_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/glycob\/9.7.731","volume":"9","author":"H Sadeghi","year":"1999","unstructured":"Sadeghi, H. & Birnbaumer, M. O-Glycosylation of the V2 vasopressin receptor. Glycobiology 9, 731\u2013737 (1999).","journal-title":"Glycobiology"},{"key":"6607_CR33","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.85.12.4335","volume":"85","author":"K Kozarsky","year":"1988","unstructured":"Kozarsky, K., Kingsley, D. & Krieger, M. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. Proc Natl Acad Sci USA 85, 4335\u20134339 (1988).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6607_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.bcp.2012.08.008","volume":"84","author":"M Szpakowska","year":"2012","unstructured":"Szpakowska, M. et al. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. Biochem Pharmacol 84, 1366\u20131380 (2012).","journal-title":"Biochem Pharmacol"},{"key":"6607_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/mol.109.056572","volume":"76","author":"GW Dorn 2nd","year":"2009","unstructured":"Dorn, G. W. 2nd & Liggett, S. B. Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure. Mol Pharmacol 76, 466\u2013480 (2009).","journal-title":"Mol Pharmacol"},{"key":"6607_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005344-200202000-00001","volume":"39","author":"DA Rathz","year":"2002","unstructured":"Rathz, D. A., Brown, K. M., Kramer, L. A. & Liggett, S. B. Amino acid 49 polymorphisms of the human \u03b21-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharm 39, 155\u2013160 (2002).","journal-title":"J Cardiovasc Pharm"},{"key":"6607_CR37","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1073\/pnas.1511175112","volume":"112","author":"CK Goth","year":"2015","unstructured":"Goth, C. K. et al. A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation. Proc Natl Acad Sci USA 112, 14623\u201314628 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6607_CR38","doi-asserted-by":"publisher","first-page":"17468","DOI":"10.1021\/ja508484c","volume":"136","author":"J Rong","year":"2014","unstructured":"Rong, J. et al. Glycan imaging in intact rat hearts and glycoproteomic analysis reveal the upregulation of sialylation during cardiac hypertrophy. J Am Chem Soc 136, 17468\u201317476 (2014).","journal-title":"J Am Chem Soc"},{"key":"6607_CR39","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1021\/acs.analchem.5b01663","volume":"87","author":"S Yang","year":"2015","unstructured":"Yang, S. et al. Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy. Anal Chem 87, 9671\u20139678 (2015).","journal-title":"Anal Chem"},{"key":"6607_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbagen.2014.09.026","volume":"1850","author":"SB Levery","year":"2015","unstructured":"Levery, S. B. et al. Advances in mass spectrometry driven O-glycoproteomics. Biochim Biophys Acta 1850, 33\u201342 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"6607_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.tibs.2015.03.002","volume":"40","author":"T Hennet","year":"2015","unstructured":"Hennet, T. & Cabalzar, J. Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction. Trends Biochem Sci 40, 377\u2013384 (2015).","journal-title":"Trends Biochem Sci"},{"key":"6607_CR42","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1074\/jbc.M110.171322","volume":"286","author":"TA Schwetz","year":"2011","unstructured":"Schwetz, T. A., Norring, S. A., Ednie, A. R. & Bennett, E. S. Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating. J Biol Chem 286, 4123\u20134132 (2011).","journal-title":"J Biol Chem"},{"key":"6607_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yjmcc.2013.02.013","volume":"59","author":"AR Ednie","year":"2013","unstructured":"Ednie, A. R., Horton, K. K., Wu, J. & Bennett, E. S. Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period and ventricular conduction. J Mol Cell Card 59, 117\u2013127 (2013).","journal-title":"J Mol Cell Card"},{"key":"6607_CR44","doi-asserted-by":"publisher","first-page":"28197","DOI":"10.1074\/jbc.M102548200","volume":"276","author":"CA Ufret-Vincenty","year":"2001","unstructured":"Ufret-Vincenty, C. A. et al. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem 276, 28197\u201328203 (2001).","journal-title":"J Biol Chem"},{"key":"6607_CR45","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.1074\/jbc.M109.096305","volume":"285","author":"L Freire-de-Lima","year":"2010","unstructured":"Freire-de-Lima, L. et al. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses. J Biol Chem 285, 13388\u201313396 (2010).","journal-title":"J Biol Chem"},{"key":"6607_CR46","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/glycob\/cwv057","volume":"25","author":"L Freire-de-Lima","year":"2015","unstructured":"Freire-de-Lima, L., Fonseca, L. M., Oeltmann, T., Mendonca-Previato, L. & Previato, J. O. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies. Glycobiology 25, 1142\u20131149 (2015).","journal-title":"Glycobiology"},{"key":"6607_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.RES.69.1.185","volume":"69","author":"SA Morris","year":"1991","unstructured":"Morris, S. A. et al. Myocardial \u03b2-adrenergic adenylate cyclase complex in a canine model of chagasic cardiomyopathy. Circ Res 69, 185\u2013195 (1991).","journal-title":"Circ Res"},{"key":"6607_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0166-6851(84)90115-4","volume":"13","author":"SA Morris","year":"1984","unstructured":"Morris, S. A., Tanowitz, H. B., Rowin, K. S., Wittner, M. & Bilezikian, J. P. Alteration of the pattern of \u03b2-adrenergic desensitization in cultured L6E9 muscle cells infected with Trypanosoma cruzi. Mol Biochem Parasitol 13, 227\u2013234 (1984).","journal-title":"Mol Biochem Parasitol"},{"key":"6607_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12016-010-8228-9","volume":"44","author":"U Nussinovitch","year":"2013","unstructured":"Nussinovitch, U. & Shoenfeld, Y. The clinical significance of anti-\u03b21-adrenergic receptor autoantibodies in cardiac disease. Clin Rev Allergy Immunol 44, 75\u201383 (2013).","journal-title":"Clin Rev Allergy Immunol"},{"key":"6607_CR50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1172\/JCI200420149","volume":"113","author":"R Jahns","year":"2004","unstructured":"Jahns, R. et al. Direct evidence for a \u03b21-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113, 1419\u20131429 (2004).","journal-title":"J Clin Invest"},{"key":"6607_CR51","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.micinf.2006.06.006","volume":"8","author":"A Talvani","year":"2006","unstructured":"Talvani, A. et al. Levels of anti-M2 and anti-\u03b21 autoantibodies do not correlate with the degree of heart dysfunction in Chagas\u2019 heart disease. Microbes Infect 8, 2459\u20132464 (2006).","journal-title":"Microbes Infect"},{"key":"6607_CR52","doi-asserted-by":"publisher","first-page":"e1005473","DOI":"10.1371\/journal.pgen.1005473","volume":"11","author":"S Marada","year":"2015","unstructured":"Marada, S. et al. Functional divergence in the role of N-linked glycosylation in smoothened signaling. PLoS Genet 11, e1005473 (2015).","journal-title":"PLoS Genet"},{"key":"6607_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1476-5381.2011.01787.x","volume":"166","author":"DI Cho","year":"2012","unstructured":"Cho, D. I. et al. The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes. Br J Pharmacol 166, 659\u2013675 (2012).","journal-title":"Br J Pharmacol"},{"key":"6607_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/mol.112.080440","volume":"83","author":"AE Hakalahti","year":"2013","unstructured":"Hakalahti, A. E. et al. \u03b2-adrenergic agonists mediate enhancement of \u03b21-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro. Mol Pharmacol 83, 129\u2013141 (2013).","journal-title":"Mol Pharmacol"},{"key":"6607_CR55","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1074\/jbc.M709851200","volume":"283","author":"N Ozgen","year":"2008","unstructured":"Ozgen, N. et al. Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart. J Biol Chem 283, 17009\u201317019 (2008).","journal-title":"J Biol Chem"},{"key":"6607_CR56","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/01.RES.68.5.1216","volume":"68","author":"SF Steinberg","year":"1991","unstructured":"Steinberg, S. F., Robinson, R. B., Lieberman, H. B., Stern, D. M. & Rosen, M. R. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res 68, 1216\u20131229 (1991).","journal-title":"Circ Res"},{"key":"6607_CR57","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1161\/01.CIR.91.11.2824","volume":"91","author":"SF Steinberg","year":"1995","unstructured":"Steinberg, S. F., Zhang, H., Pak, E., Pagnotta, G. & Boyden, P. A. Characteristics of the \u03b2-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart. Circulation 91, 2824\u20132833 (1995).","journal-title":"Circulation"},{"key":"6607_CR58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/01.RES.68.5.1216","volume":"68","author":"SF Steinberg","year":"1991","unstructured":"Steinberg, S. F., Robinson, R. B., Lieberman, H. B., Stern, D. M. & Rosen, M. R. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res 68, 1216\u20131229 (1991).","journal-title":"Circ Res"},{"key":"6607_CR59","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/CIRCRESAHA.108.187880","volume":"104","author":"D Soto","year":"2009","unstructured":"Soto, D., De Arcangelis, V., Zhang, J. & Xiang, Y. Dynamic protein kinase A activities induced by \u03b2-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction. Circ Res 104, 770\u2013779 (2009).","journal-title":"Circ Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06607-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:49:25Z","timestamp":1750783765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06607-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6607"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06607-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.728378518.793541163","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]},"assertion":[{"value":"30 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7890"}}